AssureCKD Joins North Forge’s Ascent Program to Accelerate Market Entry for Kidney Screening and Diagnostic Platform
AssureCKD, a Canadian medical device company developing point-of-care solutions for chronic kidney disease (CKD) detection, is pleased to announce its acceptance into North Forge Technology Exchange’s Ascent Program, a 12-24 month incubator designed to help companies prepare their innovations for market launch and growth.
The Ascent Program supports ventures that have developed their business model canvas, financials, and minimum viable product (MVP), and are ready to refine their go-to-market strategy and demonstrate market traction. Over the course of the program, AssureCKD will gain:
One-on-one guidance from a North Forge Entrepreneur-in-Residence.
Access to experienced mentors, business experts, and growth coaches across multiple disciplines.
Fundraising knowledge and planning support, including connections to the North Forge Angel Network.
Free or discounted business services and access to co-working or low-cost office space.
Training to strengthen investor pitch presentations and develop a market-ready growth strategy.
Introductions to strategic partners through North Forge’s extensive network.
“Our acceptance into North Forge’s Ascent Program marks a key step in getting MATLOC ready for market,” said Harrison Ross, CEO of AssureCKD. “The resources, mentorship, and strategic connections provided by North Forge will help us sharpen our commercialization strategy, validate our business model, and position us for investor and customer traction.”
About AssureCKD
AssureCKD is developing MATLOC, a lab-equivalent diagnostic platform designed to screen, diagnose, and monitor chronic kidney disease at the point-of-care. By enabling rapid, accessible, and cost-effective testing in primary care and decentralized settings, AssureCKD aims to increase screening rates and facilitate earlier intervention, ultimately improving outcomes and reducing expensive healthcare costs.